Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes: a parallel-group prospective cohort study in two sub-Saharan Africa populations
Objectives: We evaluated the importance of ethnicity and pharmacogenetic variations in determining efavirenz pharmacokinetics, auto-induction and immunological outcomes in two African populations. Methods: ART naïve HIV patients from Ethiopia (n = 285) and Tanzania (n = 209) were prospectively enro...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
July 5, 2013
|
| In: |
PLOS ONE
Year: 2013, Volume: 8, Issue: 7, Pages: 1-13 |
| ISSN: | 1932-6203 |
| DOI: | 10.1371/journal.pone.0067946 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1371/journal.pone.0067946 Verlag, lizenzpflichtig, Volltext: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067946 |
| Author Notes: | Eliford Ngaimisi, Abiy Habtewold, Omary Minzi, Eyasu Makonnen, Sabina Mugusi, Wondwossen Amogne, Getnet Yimer, Klaus-Dieter Riedel, Mohammed Janabi, Getachew Aderaye, Ferdinand Mugusi, Leif Bertilsson, Eleni Aklillu, Juergen Burhenne |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1778211321 | ||
| 003 | DE-627 | ||
| 005 | 20230426075246.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211122s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1371/journal.pone.0067946 |2 doi | |
| 035 | |a (DE-627)1778211321 | ||
| 035 | |a (DE-599)KXP1778211321 | ||
| 035 | |a (OCoLC)1341423790 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ngaimisi, Eliford |e VerfasserIn |0 (DE-588)1197814523 |0 (DE-627)1679539558 |4 aut | |
| 245 | 1 | 0 | |a Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes |b a parallel-group prospective cohort study in two sub-Saharan Africa populations |c Eliford Ngaimisi, Abiy Habtewold, Omary Minzi, Eyasu Makonnen, Sabina Mugusi, Wondwossen Amogne, Getnet Yimer, Klaus-Dieter Riedel, Mohammed Janabi, Getachew Aderaye, Ferdinand Mugusi, Leif Bertilsson, Eleni Aklillu, Juergen Burhenne |
| 264 | 1 | |c July 5, 2013 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.11.2021 | ||
| 520 | |a Objectives: We evaluated the importance of ethnicity and pharmacogenetic variations in determining efavirenz pharmacokinetics, auto-induction and immunological outcomes in two African populations. Methods: ART naïve HIV patients from Ethiopia (n = 285) and Tanzania (n = 209) were prospectively enrolled in parallel to start efavirenz based HAART. CD4+ cell counts were determined at baseline, 12, 24 and 48 weeks. Plasma and intracellular efavirenz and 8-hydroxyefvairenz concentrations were determined at week 4 and 16. Genotyping for common functional CYP2B6, CYP3A5, ABCB1, UGT2B7 and SLCO1B1 variant alleles were done. Result: Patient country, CYP2B6*6 and ABCB1 c.4036A>G (rs3842A>G) genotype were significant predictors of plasma and intracellular efavirenz concentration. CYP2B6*6 and ABCB1 c.4036A>G (rs3842) genotype were significantly associated with higher plasma efavirenz concentration and their allele frequencies were significantly higher in Tanzanians than Ethiopians. Tanzanians displayed significantly higher efavirenz plasma concentration at week 4 (p<0.0002) and week 16 (p = 0.006) compared to Ethiopians. Efavirenz plasma concentrations remained significantly higher in Tanzanians even after controlling for the effect of CYP2B6*6 and ABCB1 c.4036A>G genotype. Within country analyses indicated a significant decrease in the mean plasma efavirenz concentration by week 16 compared to week 4 in Tanzanians (p = 0.006), whereas no significant differences in plasma concentration over time was observed in Ethiopians (p = 0.84). Intracellular efavirenz concentration and patient country were significant predictors of CD4 gain during HAART. Conclusion: We report substantial differences in efavirenz pharmacokinetics, extent of auto-induction and immunologic recovery between Ethiopian and Tanzanian HIV patients, partly but not solely, due to pharmacogenetic variations. The observed inter-ethnic variations in efavirenz plasma exposure may possibly result in varying clinical treatment outcome or adverse event profiles between populations. | ||
| 650 | 4 | |a Africa | |
| 650 | 4 | |a African people | |
| 650 | 4 | |a Alleles | |
| 650 | 4 | |a Antiretroviral therapy | |
| 650 | 4 | |a Highly-active antiretroviral therapy | |
| 650 | 4 | |a HIV | |
| 650 | 4 | |a Pharmacokinetics | |
| 650 | 4 | |a Population genetics | |
| 700 | 1 | |a Habtewold, Abiy |e VerfasserIn |4 aut | |
| 700 | 1 | |a Minzi, Omary |e VerfasserIn |4 aut | |
| 700 | 1 | |a Makonnen, Eyasu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mugusi, Sabina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Amogne, Wondwossen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yimer, Getnet |e VerfasserIn |4 aut | |
| 700 | 1 | |a Riedel, Klaus-Dieter |e VerfasserIn |0 (DE-588)1034229605 |0 (DE-627)745128432 |0 (DE-576)381859460 |4 aut | |
| 700 | 1 | |a Janabi, Mohammed |e VerfasserIn |4 aut | |
| 700 | 1 | |a Aderaye, Getachew |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mugusi, Ferdinand |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bertilsson, Leif |e VerfasserIn |4 aut | |
| 700 | 1 | |a Aklillu, Eleni |e VerfasserIn |4 aut | |
| 700 | 1 | |a Burhenne, Jürgen |d 1963- |e VerfasserIn |0 (DE-588)1034228889 |0 (DE-627)745126987 |0 (DE-576)381858197 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t PLOS ONE |d San Francisco, California, US : PLOS, 2006 |g 8(2013), 7, Artikel-ID e67946, Seite 1-13 |h Online-Ressource |w (DE-627)523574592 |w (DE-600)2267670-3 |w (DE-576)281331979 |x 1932-6203 |7 nnas |a Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes a parallel-group prospective cohort study in two sub-Saharan Africa populations |
| 773 | 1 | 8 | |g volume:8 |g year:2013 |g number:7 |g elocationid:e67946 |g pages:1-13 |g extent:13 |a Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes a parallel-group prospective cohort study in two sub-Saharan Africa populations |
| 856 | 4 | 0 | |u https://doi.org/10.1371/journal.pone.0067946 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0067946 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20211122 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 1034228889 |a Burhenne, Jürgen |m 1034228889:Burhenne, Jürgen |d 910000 |d 910100 |e 910000PB1034228889 |e 910100PB1034228889 |k 0/910000/ |k 1/910000/910100/ |p 14 |y j | ||
| 999 | |a KXP-PPN1778211321 |e 4004539234 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Eliford Ngaimisi, Abiy Habtewold, Omary Minzi, Eyasu Makonnen, Sabina Mugusi, Wondwossen Amogne, Getnet Yimer, Klaus-Dieter Riedel, Mohammed Janabi, Getachew Aderaye, Ferdinand Mugusi, Leif Bertilsson, Eleni Aklillu, Juergen Burhenne"]},"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"July 5, 2013"}],"id":{"doi":["10.1371/journal.pone.0067946"],"eki":["1778211321"]},"physDesc":[{"extent":"13 S."}],"relHost":[{"title":[{"title":"PLOS ONE","title_sort":"PLOS ONE"}],"part":{"text":"8(2013), 7, Artikel-ID e67946, Seite 1-13","volume":"8","extent":"13","year":"2013","pages":"1-13","issue":"7"},"pubHistory":["1.2006 -"],"recId":"523574592","corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"Public Library of Science"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes a parallel-group prospective cohort study in two sub-Saharan Africa populationsPLOS ONE","note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"id":{"eki":["523574592"],"zdb":["2267670-3"],"issn":["1932-6203"]},"origin":[{"publisherPlace":"San Francisco, California, US ; Lawrence, Kan.","dateIssuedDisp":"2006-","dateIssuedKey":"2006","publisher":"PLOS ; PLoS"}],"name":{"displayForm":["Public Library of Science"]},"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"given":"Eliford","family":"Ngaimisi","role":"aut","display":"Ngaimisi, Eliford","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Habtewold, Abiy","given":"Abiy","family":"Habtewold"},{"role":"aut","display":"Minzi, Omary","roleDisplay":"VerfasserIn","given":"Omary","family":"Minzi"},{"family":"Makonnen","given":"Eyasu","roleDisplay":"VerfasserIn","display":"Makonnen, Eyasu","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Mugusi, Sabina","given":"Sabina","family":"Mugusi"},{"given":"Wondwossen","family":"Amogne","role":"aut","display":"Amogne, Wondwossen","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Yimer, Getnet","given":"Getnet","family":"Yimer"},{"role":"aut","display":"Riedel, Klaus-Dieter","roleDisplay":"VerfasserIn","given":"Klaus-Dieter","family":"Riedel"},{"given":"Mohammed","family":"Janabi","role":"aut","roleDisplay":"VerfasserIn","display":"Janabi, Mohammed"},{"given":"Getachew","family":"Aderaye","role":"aut","display":"Aderaye, Getachew","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Mugusi, Ferdinand","given":"Ferdinand","family":"Mugusi"},{"given":"Leif","family":"Bertilsson","role":"aut","roleDisplay":"VerfasserIn","display":"Bertilsson, Leif"},{"family":"Aklillu","given":"Eleni","roleDisplay":"VerfasserIn","display":"Aklillu, Eleni","role":"aut"},{"role":"aut","display":"Burhenne, Jürgen","roleDisplay":"VerfasserIn","given":"Jürgen","family":"Burhenne"}],"title":[{"subtitle":"a parallel-group prospective cohort study in two sub-Saharan Africa populations","title":"Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes","title_sort":"Importance of ethnicity, CYP2B6 and ABCB1 genotype for efavirenz pharmacokinetics and treatment outcomes"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 22.11.2021"],"language":["eng"],"recId":"1778211321"} | ||
| SRT | |a NGAIMISIELIMPORTANCE5201 | ||